Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vana Darou Gostar is a prominent Iranian pharmaceutical company established in 2002 and headquartered in Tehran. The company focuses on the production, importation, and distribution of a wide array of healthcare products, including finished dosage forms, active pharmaceutical ingredients, and nutritional supplements. Their therapeutic portfolio covers critical areas such as cardiovascular health, gastroenterology, neurology, and metabolic disorders. Vana Darou Gostar operates state-of-the-art manufacturing facilities that comply with international GMP standards, ensuring the quality of their generic and branded medications. In addition to local production, the company maintains strong collaborations with global pharmaceutical partners to expand access to innovative treatments in the region. Their Vana brand is a recognized leader in the Iranian dietary supplement market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vana Darou Gostar Pharmaceutical.